PL3289092T3 - Sposób wytwarzania białka terapeutycznego - Google Patents

Sposób wytwarzania białka terapeutycznego

Info

Publication number
PL3289092T3
PL3289092T3 PL16787029T PL16787029T PL3289092T3 PL 3289092 T3 PL3289092 T3 PL 3289092T3 PL 16787029 T PL16787029 T PL 16787029T PL 16787029 T PL16787029 T PL 16787029T PL 3289092 T3 PL3289092 T3 PL 3289092T3
Authority
PL
Poland
Prior art keywords
manufacturing
therapeutic protein
therapeutic
protein
Prior art date
Application number
PL16787029T
Other languages
English (en)
Inventor
Rasheed Tijani
Darryl Bacon SAMPEY
John ROBBLEE
Gan Wei
Chaomei He
Original Assignee
Momenta Pharmaceuticals, Inc.
Biofactura Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals, Inc., Biofactura Inc. filed Critical Momenta Pharmaceuticals, Inc.
Publication of PL3289092T3 publication Critical patent/PL3289092T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/0127—3Beta-hydroxysteroid 3-dehydrogenase (1.1.1.270)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
    • C12Y603/01002—Glutamate-ammonia ligase (6.3.1.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL16787029T 2015-04-27 2016-04-27 Sposób wytwarzania białka terapeutycznego PL3289092T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562153178P 2015-04-27 2015-04-27
PCT/US2016/029472 WO2016176275A1 (en) 2015-04-27 2016-04-27 Methods of manufacturing therapeutic proteins
EP16787029.4A EP3289092B1 (en) 2015-04-27 2016-04-27 Method of manufacturing a therapeutic protein

Publications (1)

Publication Number Publication Date
PL3289092T3 true PL3289092T3 (pl) 2020-07-13

Family

ID=57199650

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16787029T PL3289092T3 (pl) 2015-04-27 2016-04-27 Sposób wytwarzania białka terapeutycznego

Country Status (9)

Country Link
US (2) US10774353B2 (pl)
EP (2) EP3289092B1 (pl)
JP (3) JP2018518985A (pl)
CN (2) CN108138214B (pl)
ES (1) ES2789073T3 (pl)
HK (1) HK1256714A1 (pl)
HU (1) HUE050105T2 (pl)
PL (1) PL3289092T3 (pl)
WO (1) WO2016176275A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE050105T2 (hu) 2015-04-27 2020-11-30 Momenta Pharmaceuticals Inc Eljárás terápiás protein gyártására

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101016543A (zh) * 2000-11-17 2007-08-15 罗切斯特大学 筛选编码抗原特异性免疫球蛋白分子或其抗原特异性片段的多核苷酸的方法
GB0123098D0 (en) * 2001-09-26 2001-11-14 Lonza Biologics Plc Use of aminoglycoside resistance gene
WO2006099369A2 (en) * 2005-03-11 2006-09-21 Regents Of The University Of Minnesota Restoration of cholesterol independence and its use as a selectable marker in cell culture
BRPI0609808A2 (pt) 2005-05-18 2011-10-11 Biofactura Inc vetor , célula hospedeira, kit, composição dos suplementos de cultura celular, e, métodos para selecionar células que possam sobreviver em meio sem colesterol, para se obter células que tenham a capacidade de sobreviver em um meio desprovido de colesterol e produzir uma proteìna heteróloga, e para expressar uma proteìna heteróloga
KR20090074198A (ko) * 2006-09-15 2009-07-06 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 세포 클론을 선별하는 방법
WO2009046978A1 (en) * 2007-10-12 2009-04-16 F. Hoffmann-La Roche Ag Protein expression from multiple nucleic acids
EP2146210A1 (en) * 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
ES2699718T3 (es) * 2009-09-15 2019-02-12 Medlmmune Ltd Células para expresión transitoria y usos de las mismas
JP2015519382A (ja) 2012-06-12 2015-07-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 治療用抗体のための医薬処方物
EP2711428A1 (en) * 2012-09-21 2014-03-26 Lonza Biologics plc. Site-specific integration
HUE050105T2 (hu) 2015-04-27 2020-11-30 Momenta Pharmaceuticals Inc Eljárás terápiás protein gyártására

Also Published As

Publication number Publication date
WO2016176275A1 (en) 2016-11-03
EP3693469A1 (en) 2020-08-12
CN113981027A (zh) 2022-01-28
EP3289092B1 (en) 2020-02-12
EP3289092A4 (en) 2018-12-12
JP2023112080A (ja) 2023-08-10
US20210102230A1 (en) 2021-04-08
HUE050105T2 (hu) 2020-11-30
CN108138214A (zh) 2018-06-08
JP2018518985A (ja) 2018-07-19
JP2021137015A (ja) 2021-09-16
CN108138214B (zh) 2021-09-21
US10774353B2 (en) 2020-09-15
US20180135090A1 (en) 2018-05-17
EP3289092A1 (en) 2018-03-07
HK1256714A1 (zh) 2019-10-04
ES2789073T3 (es) 2020-10-23

Similar Documents

Publication Publication Date Title
IL249955A0 (en) A method for the computational design of proteins
HK1252568A1 (zh) 一種治療方法
EP3398466A4 (en) MASSAGE SHOE AND METHOD FOR MANUFACTURING THE SAME
GB201716774D0 (en) Method of manufacturing fluorescent-material-containing member
HK1247818A1 (zh) 治療疾病的方法
HK1258994A1 (zh) 用於疾病治療的方法
GB201518792D0 (en) Production of proteins
SG11201703184SA (en) A method of treatment
IL262544A (en) A method for producing a recombinant protein
IL252712A0 (en) Method for protein production
GB2548706B (en) Method of manufacturing fluorescent-material-containing member
GB201609170D0 (en) Method of manufacture
HK1250243A1 (zh) 治療方法
HK1246679A1 (zh) 絲蟲病的治療
HK1243937A1 (zh) 治療疾病的方法
SG11201708751RA (en) Method of producing a recombinant protein
PL3383615T3 (pl) Sposób formowania części
GB201613971D0 (en) Method of manufacture
GB201609171D0 (en) Method of manufacture
HK1256714A1 (zh) 製備治療性蛋白質的方法
ZA201607831B (en) Method of manufacturing a sausage
GB2555309B (en) A method of manufacturing a sterilized sachet
ZA201801289B (en) Method of manufacturing hydrocarbons
IL251740B (en) A method for producing vials of recombinant protein
GB201700099D0 (en) Therapeutic method